₹1,963.60
−0.26%NSE close, 16 Nov 2026
+80.26%
Entero Healthcare Solutions is a small cap company in the Consumer Services sector, listed on NSE under the symbol ENTERO. At ₹1,963.60 a share, the market values the whole company at ₹8,546 crore.
In FY26, it reported sales of ₹6,591 crore and a net profit of ₹115 crore, an operating margin of 4.0%.
The market values the company at 61.3 times its profit over the last twelve months and 4.80 times its book value; its return on equity is 7.8% and its borrowings are 0.45 times its equity.
Promoters hold 52.40% of the shares. Foreign institutions hold 5.77%, and domestic institutions, mutual funds among them, 21.16%.
Over the past year the share price has risen 85.7%, and it is 8.1% below its 52-week high.
Companies of a similar size in the same sector include Lemon Tree Hotels, Indiamart Intermesh, Aditya Birla Lifestyle Brands and BLS International Services.
₹ crore. Consolidated figures.
The same sector (Consumer Services), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| Entero Healthcare Solutions | ₹1,963.60 | ₹8,546 cr | 61.3 | 7.8% | +32.90% | +85.67% |
| Lemon Tree Hotels | ₹124.18 | ₹9,838 cr | 38.3 | 17.1% | +18.00% | −25.22% |
| Indiamart Intermesh | ₹1,574.60 | ₹9,470 cr | 18.9 | 21.7% | +9.60% | −36.33% |
| Aditya Birla Lifestyle Brands | ₹77.29 | ₹9,433 cr | 45.9 | 14.3% | +11.20% | −41.63% |
| BLS International Services | ₹225.07 | ₹9,267 cr | 12.9 |
Transcript
Link of Recording
Link of Recording
Written from the company's filings with NSE and the exchanges' daily prices. For information only, not a recommendation to buy, sell or hold any security.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 993 | 1,034 | 1,097 | 1,301 | 1,359 | 1,339 | 1,404 | 1,571 | 1,707 | 1,910 | 1,941 | 2,087 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 964 | 1,005 | 1,067 | 1,258 | 1,309 | 1,290 | 1,354 | 1,509 | 1,639 | 1,824 | 1,844 | 1,976 |
| Operating profit | 28.6 | 28.9 | 30.2 | 42.5 | 50.0 | 48.9 | 50.1 | 62.1 | 67.8 | 86.0 | 97.0 | 111 |
| Operating margin | 2.9% | 2.8% | 2.8% | 3.3% | 3.7% | 3.7% | 3.6% | 4.0% | 4.0% | 4.5% | 5.0% | 5.3% |
| Other income | 1.8 | 9.2 | 13.4 | 11.3 | 7.5 | 7.3 | 5.8 | 4.8 | 4.6 | 4.0 | 3.0 | 4.0 |
| Interest | 16.1 | 17.3 | 9.7 | 11.5 | 10.0 | 10.5 | 10.7 | 12.4 | 14.0 | 17.3 | 20.6 | 23.1 |
| Depreciation | 6.0 | 7.1 | 6.6 | 7.5 | 8.1 | 8.5 | 8.9 | 9.8 | 9.8 | 14.8 | 12.3 | 13.1 |
| Profit before tax | 8.3 | 13.6 | 27.3 | 34.8 | 39.4 | 37.2 | 36.4 | 44.6 | 40.4 | 58.0 | 67.1 | 78.4 |
| Tax | 1.3 | −7.6 | 6.8 | 8.7 | 10.0 | 5.8 | 6.1 | 8.0 | 6.5 | 12.8 | 15.1 | 17.7 |
| Net profit | 6.8 | 21.0 | 20.5 | 23.6 | 25.4 | 25.7 | 27.8 | 31.6 | 27.6 | 28.0 | 38.2 | 45.5 |
| EPS (₹) | 1.91 | 5.73 | 4.62 | 5.43 | 5.85 | 5.91 | 6.39 | 7.26 | 6.35 | 6.44 | 8.77 | 10.47 |
₹ crore, financial years to March.
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | −76.9 | 96.2 | −46.5 |
| From investing | 220 | −303 | −180 |
| From financing | −73.7 | 124 | 176 |
| Spent on fixed assets | −11.3 | −67.5 | −22.5 |
| Free cash flow | −88.2 | 28.7 | −69.1 |
Margins, returns, debt, tax and cash.
| Line | FY25 | FY26 |
|---|---|---|
| Net margin | 1.9% | 1.7% |
| Operating margin | 3.4% | 4.0% |
| Return on equity | 5.5% | 6.8% |
| Return on capital employed | 8.9% | 10.4% |
| Return on assets | 3.5% | 3.2% |
| Debt to equity | 0.17 | 0.34 |
| Interest coverage | 4.30 | 4.30 |
| Debt to assets | 0.11 | 0.16 |
| Current ratio | 2.46 | 1.58 |
| Quick ratio | 1.68 | 1.05 |
| Cash ratio | 0.27 | 0.09 |
| Asset turnover | 1.89 | 1.83 |
| Fixed asset turnover | 38.59 | 63.92 |
| Inventory turnover | 7.00 | 7.00 |
| Receivables turnover | 6.10 | 5.40 |
| Gross margin | 9.5% | 10.3% |
| Cash from operations to profit | -81.0% | 84.0% |
| Effective tax rate | 22.6% | 18.7% |
| 25.4% |
| +32.00% |
| −29.53% |
| Brainbees Solutions | ₹158.59 | ₹8,280 cr | n/a | -2.0% | +14.10% | −53.95% |
|---|
| Medplus Health Services | ₹618.60 | ₹7,432 cr | 35.2 | 10.2% | +21.30% | −21.21% |
|---|
| Aditya Vision | ₹569.10 | ₹7,349 cr | 50.9 | 18.8% | +28.10% | +6.01% |
|---|
| Le Travenues Technology | ₹165.86 | ₹7,316 cr | 48.9 | 6.9% | +13.50% | −39.96% |
|---|
Grant of 49712 Options.
The financial results for the period ended September 30, 2026.
Schedule of meet
Allotment of Equity Shares upon exercise of stock options under the Entero Employee Stock Option Plan 2023
Completion of tenure of Mr. Rajesh Shashikant Dalal
Proceedings of Annual General Meeting held on August 19, 2026. Further, the company has submitted the Exchange a copy of Scrutinizers report along with voting results.
The financial results for the period ended Jun 30, 2026.
Revised intimation of the Earnings Call on the Unaudited Financial Results of the Company for the Quarter Ended June 30, 2026